ProMED-AMR, a partnership between ISID and Public Health England is set to bolster global AMR surveillance
The International Society for Infectious Diseases’ (ISID) Program for Monitoring Emerging Diseases (ProMED) is announcing its partnership with Public Health England (PHE), on behalf of the UK’s Department of Health and Social Care, to bolster global antimicrobial resistance (AMR) surveillance through technology transfer, monitoring and evaluation, and information exchange.
The widespread use of antimicrobials, (including their overuse in animals and humans), gaps in infection prevention and control, and inadequate disease surveillance diminishes our arsenal of tools to treat and prevent resistant infections. The goal of the partnership is to improve situational awareness surrounding AMR and empower astute practitioners with useful data. This formal collaborative project showcases the strength and reach brought together by two leading public health organizations, focusing on lower- and middle-income countries (LMICs).
OUR UNDERWRITERS
Unrestricted financial support by:
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
 |
BD |
AMR NEWS
Your Biweekly Source for Global AMR Insights!
Stay informed with the essential newsletter that brings together all the latest One Health news on antimicrobial resistance. Delivered straight to your inbox every two weeks, AMR NEWS provides a curated selection of international insights, key publications, and the latest updates in the fight against AMR.
Don’t miss out on staying ahead in the global AMR movement—subscribe now!